University of Kansas Cancer Center Post San Antonio Review
2021
University of Kansas Cancer Center Post San Antonio Review
42 y/o With cT2N Grade III TNBC: Does Inclusion of CPIs & Carboplatin in the Neoadjuvant Regimen Influence Recommendation for Adjuvant Capecitabine? What About Adjuvant Pembro? How to Counsel Regarding ctDNA Monitoring?
- 161 views
- February 28, 2021
University of Kansas Cancer Center Post San Antonio Review
Expert Discussion on Challenging BC Cases: What Treatment Option to Consider for HER2+ De-Novo mBC? What Is the Best 1L Option for T2N0 TNBC Treated With NA AC-T? Does BRCA Status Impact the Choice of Chemo Backbone for IO?
- 177 views
- February 28, 2021
- 2
University of Kansas Cancer Center Post San Antonio Review
SABCS Data on mTNBC: 1L Chemo + IO in PD-L1+ Disease, Sacituzumab Govitecan, 1L AKTi + Chemo
FEATURING
Sara Tolaney
- 225 views
- February 28, 2021
- 2
University of Kansas Cancer Center Post San Antonio Review
Endocrine Resistance in BC: Mechanisms and Treatment Strategies
FEATURING
Justin Balko
- 142 views
- February 28, 2021
University of Kansas Cancer Center Post San Antonio Review
Predictive & Prognostic Biomarkers in Neoadjuvant TNBC: How Valuable Is pCR? Do HRD, DDR & Genomics Have Potential Prognostic Implication? Can SoC AC-T Chemo Backbone Be Reduced? What Is the Importance of TILs?
FEATURING
Aditya Bardia
- 376 views
- February 23, 2021
- 5